Sisi Chen
Key Laboratory Of Translational Cancer Stem Cell Research
Changsha, China
Changsha, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Dysregulated Ribosome Biogenesis Is a Targetable Vulnerability in Triple-Negative Breast Cancer: MRPS27 as a Key Mediator of the Stemness-inhibitory Effect of Lovastatin.
Journal: International journal of biological sciences
Published: January 09, 2024
Hexokinase 2 Is a Pivot for Lovastatin-induced Glycolysis-to-Autophagy Reprogramming in Triple-Negative Breast Cancer Cells.
Journal: Journal of Cancer
Published: January 30, 2022
Lovastatin enhances chemosensitivity of paclitaxel-resistant prostate cancer cells through inhibition of CYP2C8.
Journal: Biochemical and biophysical research communications
Published: November 23, 2021
Natural products inducing nucleolar stress: implications in cancer therapy.
Journal: Anti-cancer drugs
Published: September 25, 2021
Nucleolar and Coiled-Body Phosphoprotein 1 Is Associated With Stemness and Represents a Potential Therapeutic Target in Triple-Negative Breast Cancer.
Journal: Frontiers in oncology
Published: August 27, 2021
Lovastatin Inhibits EMT and Metastasis of Triple-Negative Breast Cancer Stem Cells Through Dysregulation of Cytoskeleton-Associated Proteins.
Journal: Frontiers in oncology
Published: January 21, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026